Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Veterinary Cardiology Market Size & Growth Forecast 2026–2035, By Segments (Animal Type, Indication, End Use, Product, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11495| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Veterinary Cardiology Market size was worth USD 2.95 Billion in 2025 and is poised to grow at a 8.4% CAGR between 2026 and 2035, attaining USD 6.61 Billion by 2035. The industry revenue for 2026 is assessed at USD 3.17 billion.

Base Year Value (2025)
USD 2.95 Billion
CAGR (2026-2035)
8.4%
Forecast Year Value (2035)
USD 6.61 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Veterinary Cardiology Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 40.79% share in 2025, supported by advanced companion animal care, specialized veterinary services, referral-based care, and higher spending on pet health.
  • Asia Pacific is projected to grow at a 9.49% CAGR as veterinary care access expands, specialty services improve, and pet owners increasingly seek advanced cardiac diagnosis and treatment.

Segment Momentum

  • Companion animals lead with 65.26% share due to higher screening rates, routine follow-ups, and stronger owner willingness to pursue specialized cardiac diagnostics and long-term treatment in dogs and cats.
  • Production animals are expanding fastest as livestock operators increasingly link cardiovascular health with productivity and breeding value, increasing demand for diagnostic evaluation from a relatively underpenetrated base.

Market Expansion Drivers

  • Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics.
  • Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions.
  • Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent companies in the veterinary cardiology market include Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Esaote S.p.A. (Italy), Sound Technologies Inc. (United States), Vmed Technology (United States), Zoetis Inc. (United States), Merck & Co., Inc. [Merck Animal Health] (United States), FUJIFILM Holdings Corporation (Japan).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics

As degenerative valve disease, cardiomyopathy, and age-related cardiac complications are identified more frequently in companion dogs, veterinarians are relying more heavily on imaging and monitoring tools that can distinguish benign murmurs from progressive heart dysfunction. This is pushing the veterinary cardiology market toward greater use of echocardiography, ECG systems, Holter monitoring, and blood pressure assessment as clinics seek earlier and more accurate evaluation before treatment decisions are made. The effect is especially visible in referral networks and multi-specialty practices, where rising caseloads are driving demand for higher-capability diagnostic platforms and strengthening service volumes tied to cardiac workups.

Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions

Higher willingness among pet owners to spend on advanced care is changing how chronic heart conditions are managed, particularly for dogs requiring long-term medication, repeat evaluations, and ongoing monitoring. In the veterinary cardiology market, this supports broader uptake of specialized therapeutics, follow-up diagnostics, wearable or ambulatory monitoring tools, and treatment plans that would previously have been deferred or limited to severe cases. As owners increasingly approach cardiac disease management with the same continuity mindset applied to other chronic companion animal conditions, clinics and specialty providers are expanding cardiology offerings, reinforcing demand for premium cardiac care pathways.

Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption

Professional education initiatives, continuing training, and awareness campaigns are improving how general practitioners recognize subtle cardiac signs and when they refer patients for specialist evaluation. This is influencing the veterinary cardiology market by moving case identification earlier in the disease pathway, when murmurs, arrhythmias, or breed-linked risks can be investigated before overt heart failure develops. In practice, stronger clinical awareness increases screening during routine visits, supports preventive monitoring for at-risk animals, and creates steadier demand for cardiology consultations and diagnostic services rather than concentrating utilization only in late-stage emergency presentations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics 2.00% Moderate North America, Asia Pacific, Europe High Near Term
Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions 1.70% Moderate North America, Europe High Mid Term
Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption 1.40% Moderate Asia Pacific, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
40.79% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 40.79% share of the veterinary cardiology market in 2025, backed by a well-established companion animal care ecosystem and broader access to specialized veterinary services. The region’s leadership is strengthened by higher utilization of advanced cardiac diagnostics, referral-based care pathways, and stronger spending on pet health, which together sustain demand for cardiology consultations, monitoring, and treatment in everyday clinical practice. A more mature base of specialty hospitals and trained veterinary professionals also helps convert cardiac case identification into procedure volume and follow-on care.

Asia Pacific is projected to expand at a 9.49% CAGR over the forecast period, with growth in the veterinary cardiology market being impelled by rising access to veterinary care and increasing adoption of specialized animal health services. As clinical capabilities improve across urban centers and pet owners become more willing to pursue diagnosis and treatment for complex conditions, demand is shifting beyond basic care toward cardiology-focused evaluation and management. This is creating stronger momentum for advanced diagnostics and specialty case handling across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Specialty Diagnostic Services

Germany strengthens the veterinary cardiology market through widespread use of advanced diagnostic imaging and referral-based specialty services. Veterinary professionals in Germany increasingly emphasize early detection and structured management of cardiac conditions in companion animals.

France 🇫🇷

Referral Care Development

France focuses on strengthening veterinary cardiology through referral networks and specialized clinical expertise for complex cardiovascular cases. Veterinary practices in France continue adopting advanced diagnostic tools that support accurate assessment and ongoing treatment planning.

Italy 🇮🇹

Specialized Veterinary Practice

Italy advances the veterinary cardiology market by expanding access to specialized cardiac care within companion animal practices. Italian veterinary professionals increasingly utilize echocardiography and other diagnostic technologies to support timely cardiovascular disease management.

Japan 🇯🇵

Preventive Cardiac Management

Japan prioritizes preventive veterinary cardiology supported by routine health assessments and growing awareness of age-related heart disease in pets. Veterinary clinics in Japan continue incorporating specialized cardiac diagnostics into comprehensive animal healthcare services.

South Korea 🇰🇷

Advanced Companion Healthcare

South Korea expands veterinary cardiology capabilities through investment in specialized pet healthcare services and modern diagnostic equipment. Veterinary providers in South Korea increasingly offer comprehensive cardiac evaluations as companion animal ownership continues evolving.

United States 🇺🇸

Companion Care Expansion

The U.S. veterinary cardiology market is supported by increasing demand for advanced cardiac diagnostics and specialist care for companion animals. Veterinary hospitals across the U.S. continue expanding access to imaging technologies and long-term cardiovascular disease management.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Veterinary Cardiology Market Share (%), Animal Type, 2025

Companion Animals
Production Animals

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Animal Type Segment Analysis: Companion Animals (Largest Segment) vs Production Animals (Fastest-Growing Segment)

Companion Animals held the leading position in the veterinary cardiology market in 2025, accounting for a 65.26% share. This leadership is underpinned by the higher frequency of cardiac screening, diagnosis, and follow-up care in dogs and cats, where owners are more likely to pursue specialized cardiology consultations and long-term treatment. The veterinary cardiology market continues to see stronger utilization in companion animals because these cases are more consistently brought into clinical settings, allowing earlier detection and more regular disease management than in other animal categories.

Production Animals are emerging as the fastest-growing segment in the veterinary cardiology market as livestock care becomes more attentive to health conditions that affect productivity, breeding value, and overall herd performance. Growth is being underpinned by increasing recognition that cardiovascular issues can carry direct economic consequences in managed animal populations, which is driving greater diagnostic attention relative to traditional care patterns. Compared with companion animals, this segment is gaining momentum from a lower established base, creating clearer room for expanded adoption of cardiology evaluation in production-focused veterinary practice.

Indication Segment Analysis: Congestive Heart Failure (Largest Segment) vs Arrhythmias (Fastest-Growing Segment)

In 2025, Congestive Heart Failure represented the largest indication in the veterinary cardiology market, with a 40.21% share. Its leading position is underpinned by the fact that heart failure cases often require ongoing clinical management, repeat assessments, and sustained therapeutic intervention once diagnosed. Within the veterinary cardiology market, this creates a steady concentration of case volume around congestive heart failure, as it is a condition that typically moves beyond one-time evaluation and into continued monitoring and treatment.

Arrhythmias are the fastest-growing indication in the veterinary cardiology market due to rising attention to rhythm abnormalities that require more precise cardiac assessment and earlier identification in clinical practice. This segment is gaining momentum as veterinary providers place greater emphasis on detecting conditions that may not be evident through routine examination alone, increasing the role of cardiology-specific evaluation. Relative to more established indications, arrhythmias are benefiting from expanding diagnostic focus, which is accelerating their growth within specialized veterinary cardiac care.

Segment Sub-Segment Largest Segment Fastest Growing
Animal Type Companion Animals, Production Animals Companion Animals Production Animals
Indication Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Others Congestive Heart Failure Arrhythmias
End Use Veterinary Hospitals & Clinics, Others Veterinary Hospitals & Clinics Veterinary Hospitals & Clinics
Product Pharmaceuticals, Diagnostics Pharmaceuticals Diagnostics
Distribution Channel Hospital/Clinic Pharmacy, Retail, E-Commerce Hospital/Clinic Pharmacy E-Commerce
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the veterinary cardiology market:

1. Boehringer Ingelheim International GmbH (Germany)

2. Ceva Santé Animale (France)

3. IDEXX Laboratories Inc. (United States)

4. Esaote S.p.A. (Italy)

5. Sound Technologies Inc. (United States)

6. Vmed Technology (United States)

7. Zoetis Inc. (United States)

8. Merck & Co. Inc. [Merck Animal Health] (United States)

9. FUJIFILM Holdings Corporation (Japan)

The veterinary cardiology market is evolving through the adoption of advanced diagnostic imaging systems and enhanced monitoring technologies designed to improve cardiac care in animals. Industry participants are increasingly introducing sophisticated solutions that support early disease detection and treatment planning, while innovation in portable and minimally invasive devices is expanding accessibility for veterinary practitioners. Rising pet healthcare expenditure is also reinforcing demand for specialized cardiology services and equipment.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Boehringer Ingelheim & Eko Health Apr-26 Boehringer Ingelheim and Eko Health launched Eko Vet+ featuring CANINEBEAT AI, an integrated diagnostic solution for the detection and grading of canine heart murmurs. By combining digital stethoscope technology with AI-driven analysis, the platform enhances diagnostic accuracy and early detection of structural heart disease in clinical veterinary settings.
Fujifilm Mar-25 Fujifilm integrated AI-automated echocardiography analysis into its LISENDO 880 ultrasound system through a partnership with Us2.ai. This technology automates complex cardiac measurements, reducing inter-observer variability and increasing diagnostic efficiency for veterinary cardiologists, thereby streamlining the assessment of cardiac structure and function in animal patients.
Boehringer Ingelheim Nov-24 Boehringer Ingelheim launched the VETMEDIN oral solution, the first FDA-approved liquid formulation for managing congestive heart failure in dogs. This innovation provides a precise, convenient alternative to traditional tablet dosing, improving compliance and therapeutic outcomes for canine patients with myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM).
Cronus Pharma Specialties Apr-24 Cronus Pharma Specialties received FDA approval for the first generic Pimomedin (pimobendan) chewable tablets. This launch increases the availability of cost-effective, clinically equivalent treatment options for canine congestive heart failure, supporting broader access to standard-of-care pharmacotherapy within the veterinary cardiology market.
Chulalongkorn University Jan-24 A veterinary surgical team at Chulalongkorn University performed Thailand's first minimally invasive mitral valve repair (MVR) on a dog using a mitral clamp. This procedure eliminates the need for cardiopulmonary bypass (artificial heart/lung machine), significantly reducing surgical trauma and recovery time, and demonstrating the advancement of interventional cardiology techniques in small animal practice.
Invoxia Jan-23 Invoxia launched a smart dog collar equipped with integrated AI and biometric sensors designed to track respiratory and cardiac vitals. Developed in collaboration with veterinary specialists, the device provides continuous health monitoring and early anomaly detection, enabling proactive intervention and longitudinal data tracking for improved preventive cardiac care in domestic canine populations.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Veterinary Cardiology Market — Custom Segments

Segment Sub-Segment
No segment data available.

Veterinary Cardiology Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of veterinary cardiology?

The market size of veterinary cardiology in 2026 is calculated to be USD 3.17 billion.

What are the growth projections for the veterinary cardiology industry?

Veterinary Cardiology Market size is predicted to expand from USD 2.95 billion in 2025 to USD 6.61 billion by 2035 with growth underpinned by a CAGR above 8.4% between 2026 and 2035.

How is rising incidence of canine cardiac conditions influencing diagnostic adoption in the veterinary cardiology market?

Increasing cases of degenerative valve disease and cardiomyopathy are driving stronger use of echocardiography, ECG, Holter monitoring, and blood pressure tools, as clinics prioritize earlier detection and more accurate differentiation of progressive heart dysfunction.

How are awareness initiatives shaping diagnostic timing and care pathways in veterinary cardiology?

Expanding professional education is enabling earlier recognition of murmurs and arrhythmias in general practice, increasing referrals and shifting diagnosis toward preventive screening rather than late-stage intervention, supporting steadier cardiology service demand.

Why do companion animals dominate the veterinary cardiology market?

Companion animals lead with 65.26% share due to higher screening rates, routine follow-ups, and stronger owner willingness to pursue specialized cardiac diagnostics and long-term treatment in dogs and cats.

What is driving faster growth in production animals?

Production animals are expanding fastest as livestock operators increasingly link cardiovascular health with productivity and breeding value, increasing demand for diagnostic evaluation from a relatively underpenetrated base.

Why does North America lead the veterinary cardiology market?

North America held a 40.79% share in 2025, supported by advanced companion animal care, specialized veterinary services, referral-based care, and higher spending on pet health.

How is Asia Pacific driving growth in the veterinary cardiology market?

Asia Pacific is projected to grow at a 9.49% CAGR as veterinary care access expands, specialty services improve, and pet owners increasingly seek advanced cardiac diagnosis and treatment.

Which companies dominate the veterinary cardiology landscape?

Prominent companies in the veterinary cardiology market include Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Esaote S.p.A. (Italy), Sound Technologies Inc. (United States), Vmed Technology (United States), Zoetis Inc. (United States), Merck & Co., Inc. [Merck Animal Health] (United States), FUJIFILM Holdings Corporation (Japan).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →